Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67,604,359
-
Total 13F shares
-
57,554,702
-
Share change
-
-397,190
-
Total reported value
-
$5,079,400,953
-
Put/Call ratio
-
72%
-
Price per share
-
$88.25
-
Number of holders
-
282
-
Value change
-
-$46,897,671
-
Number of buys
-
144
-
Number of sells
-
155
Institutional Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q1 2021
As of 31 Mar 2021,
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) was held by
282 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,554,702 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, Jackson Square Partners, LLC, BlackRock Inc., Capital World Investors, CREDIT SUISSE AG/, Invesco Ltd., Champlain Investment Partners, LLC, FEDERATED HERMES, INC., and BROWN CAPITAL MANAGEMENT LLC.
This page lists
282
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.